MTOR and neoplasm: We found that various tumour signaling pathways were activated in the ARS-high group, such as IL2/STAT5 signaling, notch signaling, P53 signaling, PI3K/AKT/mTOR signaling, TGF β signaling, and Wnt/β-catenin signaling.